State Of Wisconsin Investment Board Magenta Therapeutics, Inc. Transaction History

State Of Wisconsin Investment Board

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$4.43 - $8.33 $116,508 - $219,079	-26,300 Closed	0 $0
Q4 2020 Feb 03, 2021	SELL	$6.1 - $7.94 $20,130 - $26,202	-3,300 Reduced 11.15%	26,300 $206,000
Q3 2020 Nov 16, 2020	SELL	$6.52 - $8.94 $54,768 - $75,096	-8,400 Reduced 22.11%	29,600 $201,000
Q2 2020 Aug 12, 2020	BUY	$6.18 - $10.76 $10,506 - $18,292	1,700 Added 4.68%	38,000 $285,000
Q1 2020 May 06, 2020	BUY	$6.03 - $15.24 $42,813 - $108,204	7,100 Added 24.32%	36,300 $228,000
Q3 2019 Nov 12, 2019	BUY	$9.63 - $14.0 $79,929 - $116,200	8,300 Added 39.71%	29,200 $300,000
Q2 2019 Aug 14, 2019	BUY	$13.4 - $17.67 $280,060 - $369,303	20,900 New	20,900 $308,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.